McKesson recalls Inflectra (infliximab-dyyb)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- cGMP Deviations: Product intended for quarantine was inadvertently distributed.
- Products
-
- Inflectra (infliximab-dyyb)
- Company
- McKesson
- Where it was sold
-
Nationwide USA
Nationwide
- Units affected
- 192 vials
- About this recall
- Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01